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The DmpA (-aminopeptidase A) protein produced by Ochro-
bactrum anthropi hydrolyses p-nitroanilide derivatives of glycine
and -alanine more efficiently than that of -alanine. When
regular peptides are utilized as substrates, the enzyme behaves as
an aminopeptidase with a preference for N-terminal residues in
an  configuration, thus exemplifying an interesting case of
stereospecificity reversal. The best-hydrolysed substrate is -Ala-
Gly-Gly, but tetra- and penta-peptides are also efficiently hydro-
lysed. The gene encodes a 375-residue precursor, but the active
enzyme contains two polypeptides corresponding to residues
2–249 (α-subunit) and 250–375 (β-subunit) of the precursor.
Residues 249 and 250 are a Gly and a Ser respectively, and
various substitutions performed by site-directed mutagenesis
INTRODUCTION
Ochrobactrum anthropi LMG7991 contains two distinct intra-
cellular enzymes that hydrolyse -alanyl-p-nitroanilide (-Ala-p-
Na) [1]. One of them, DmpB (-aminopeptidase B), is homo-
logous to the -alanyl aminopeptidase described by Asano et al.
[2,3], and has very similar catalytic properties. The second
enzyme, DmpA, is produced in much smaller quantities by the
original strain. A DNA fragment was isolated that encoded an
original 375-residue open reading frame (ORF) and whose
integration in the pUC18 plasmid downstream of the lacZ
promoter resulted in the production of large amounts of -Ala-
p-Na-hydrolysing activity. These experiments suggested strongly
that this ORF represented the DmpA structural gene [1]. In this
study, we describe the purification of the cloned DmpA protein
and demonstrate that the 375-residue precursor is activated by a
probably autocatalytic cleavage between residues 249 and 250. A
detailed analysis of this cleavage site indicates that its properties
are strikingly similar to those of N-terminal nucleophile (N-tn)
amidohydrolases. Exploration of the databases (available at the
website of the National Center of Biotechnology Information,
http:!!www.ncbi.nlm.nih.gov) shows that DmpA is the pro-
totype of a new family of N-tn hydrolases. The catalytic
properties of the enzyme are also analysed.
MATERIALS AND METHODS
Molecular biology, oligonucleotides, kits, enzymes, chemicals and
other materials
Components of culture media were from Difco (Detroit, MI,
U.S.A.) and Biome! rieux (Marcy-l’Etoile, France). Sequencing
Abbreviations used: Dmp, D-aminopeptidase; ORF, open reading frame; D-Ala-p-Na, D-alanyl-p-nitroanilide ; N-tn ; N-terminal nucleophile ; LB,
Luria–Bertani ; QSFF, Q–Sepharose Fast-Flow.
1 To whom correspondence should be addressed (e-mail jmfrere!ulg.ac.be).
result in the production of an uncleaved and inactive protein.
The N-terminal Ser residue of the β-subunit is followed by a
hydrophobic peptide, which is predicted to form a β-strand
structure. All these properties strongly suggest that DmpA is an
N-terminal amidohydrolase. An exploration of the databases
highlights the presence of a number of open reading frames
encoding related proteins in various bacterial genomes. Thus
DmpA is very probably the prototype of an original family of N-
terminal hydrolases.
Key words: N-terminal nucleophile amidohydrolase, peptidase,
protease precursor, stereospecificity.
kits, oligonucleotides, plasmids, purification supports and
columns were purchased from Pharmacia Biotech (Uppsala,
Sweden). The QuickChange Site-Directed Mutagenesis kit was a
Stratagene product (La Jolla, CA, U.S.A.). The p-nitroanilide
and peptide substrates were from Bachem (Bubendorf, Switzer-
land) and Sigma (Bornem, Belgium), and protease inhibitors
were from Boehringer Mannheim (Mannheim, Germany) or
Worthington (Stoke-on-Trent, Staffs, U.K.). The DNA laser
sequenators were from Pharmacia Biotech and EMBL (Heidel-
berg, Germany). The Cybertech CS-1 system (Cybertech, Berlin,
Germany) was used to quantify proteins on gels after SDS!
PAGE. The Constant Basic System Disintegrator was from
Inceltech (Toulouse, France). Protein purification was performed
with the help of anA" ktaExplorer apparatus (PharmaciaBiotech).
The VG Bio-Q Electrospray Triple Quadrupole Mass analyser,
upgraded with a platform source, was from Micromass
(Altrincham, Cheshire, U.K.), and was connected to a Harvard
11 syringe pump (Harvard Instruments, South Natick, MA,
U.S.A.). The TLC plates (Silica gel 60F250) were from Merck
(Darmstadt, Germany).
Purification of the DmpA protein produced by Escherichia coli
DH5α
After transformation with pDML1102 [1], 2–3 colonies pro-
ducing -Ala-p-Na-hydrolysing activity were inoculated in
250 ml of Luria–Bertani (LB) medium containing ampicillin
(50 µg!ml) and cultured during 16 h at 37 !C. Aliquots of this
preculture were diluted 500 times in the same medium and the
culture incubated for 16 h at 37 !C. The presence of inclusion
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Figure 1 Oligonucleotides designed for mutagenesis of the DmpA cleavage site and plasmids utilized for production of the mutants
WT, wild type.
bodies in the E. coli cells was detected by examination of the cells
by phase-contrast microscopy.
Extraction of inclusion bodies
Culture (50 ml) was centrifuged and cells were resuspended in
10 ml of 10 mM Tris!HCl buffer, pH 8.0, containing 1 mM
EDTA (buffer A). Inclusion bodies were then extracted as
described by Goraj et al. [4].
Purification of the soluble active protein
The soluble fraction of DmpA was purified to more than 95% as
follows: 1 litre of culture was centrifuged and cells were resus-
pended in 50 ml of buffer A. Cells were disrupted with the
Constant Basic System Disintegrator and the suspension centri-
fuged. Activity towards -Ala-p-Na was detected in the super-
natant. After dialysis against 50 mM potassium phosphate,
pH 6.0, the protein solution was loaded on to a 200-ml Q–
Sepharose Fast-Flow (QSFF) column (40 cm"2.5 cm) equili-
brated in the same buffer, and eluted with a 0–0.3 M NaCl
linear gradient over a volume of 2 litres. Active fractions were
pooled and dialysed against buffer A or diluted twice with
20 mM Tris!HCl, pH 8.0. The sample was then loaded on to the
QSFF column equilibrated with buffer A and eluted with a
0.2–0.5 M NaCl linear gradient under the same conditions as
above. Active fractions were pooled and the pure protein (60 mg)
dialysed against 50 mM potassium phosphate, pH 7.0, concen-
trated and stored at #20 !C.
Immunodetection of the DmpA
Rabbit antibodies against the purified DmpA enzyme produced
in E. coli were prepared by Gamma (Lie# ge, Belgium). After
SDS!PAGE, electroblotting on to a nitrocellulose membrane
and treatment with antibodies, positive bands were revealed with
the help of the Bio-Rad ImmunoBlot Alkaline Phosphatase
Assay System (Bio-Rad, Nazareth, Belgium). After blotting,
standard proteins were stained with 0.1% (w!v) Ponceau S Red
in 5% (v!v) acetic acid and the membrane was rinsed with water.
Prestained standard proteins (low-range, Bio-Rad) were also
used.
Site-directed mutagenesis of the DmpA cleavage site
To assess the importance of the two residues constituting the
cleavage site, the Gly-249 residue was replaced successively by
Ala (the least-disturbing possible modification) and Asp. Con-
versely, the Ser-250 residue was replaced by residues possessing
potential nucleophilic groups in their side chains and sometimes
encountered in N-tn hydrolases (Thr or Cys) and by a residue
devoid of such properties (Ala). The experiments were performed
with the help of the QuickChange Site-Directed Mutagenesis
kit (Stratagene), according to the supplied protocol. Oligo-
nucleotides used for the mutagenesis reaction are described in
Figure 1. The PCR reactions introducing the mutations were
performed directly with the pDML1102 plasmid as a template.
The reaction mixture contained 10 ng of DNA matrix (40 ng for
the S250T mutation), 125 ng of each oligonucleotide (the S250T
oligonucleotides were incubated previously for 10 min at 95 !C
to denature the secondary structures), all dNTPs at 0.05 mM and
2.5 Pfu polymerase units, in a total volume of 50 µl. After
heating for 30 s at 95 !C, PCR reactions were performed as
follows: 1 min at 55 !C, 8 min at 68 !C, 12 cycles to replace one
base, 16 cycles to replace two bases and for the S250T mutation.
After completion of the PCR reactions and digestion of the non-
mutated DNA matrix with the DpnI enzyme, 1 µl of each PCR
mixture was used to directly transform XL1Blue E. coli super-
competent cells purchased with the mutagenesis kit. Trans-
formed cells were plated on LB$ampicillin and grown for 16 h
at 37 !C. Plasmids extracted from the various clones were
analysed by restriction (the G249A mutation created a second
BssHII GCGCGC site in the dmpA gene) and sequenced on both
strands for verification of the presence of the mutation. Plasmids
containing themutated dmpA genewere named pDML1103–1107
according to the mutation (see Figure 1) and were then used to
transform E. coli DH5α cells to produce the corresponding
proteins.
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Figure 2 Electrophoretic analysis of DmpA samples
Panel I, Coomassie Brilliant Blue staining of the gel (a) and immunoblot revealed with rabbit anti-DmpA antibodies (b) after SDS/PAGE (18% polyacrylamide) of the following samples : MM STDS,
Gibco-BRL protein molecular-mass standards (kDa) ; lanes 1, inclusion bodies from E. coli containing the uncleaved putative DmpA precursor (Prc.). Note that the intensity of the bands appearing
at lower Mr values was found to increase with time upon strorage of the inclusion bodies, a result which suggested that these bands might represent degradation products of the 45000-Mr antibody-
recognized protein. Lanes 2, active soluble DmpA purified from E. coli (N. Term. and C. Term., N- and C-terminal fragments) ; lanes 3, active DmpA partially purified from O. anthropi LMG7991
(fraction containing the highest activity after chromatography on the Superdex 75 molecular-sieve column [1]) ; lanes 4, soluble fraction of the total cell extract of O. anthropi LMG7991. Panel II,
Coomassie Brilliant Blue staining of the gel (c) and immunoblot revealed with rabbit anti-DmpA antibodies (d) after electrophoresis on non-denaturing 8% polyacrylamide gel of the following samples :
lanes 1, partially purified DmpA from O. anthropi LMG7991 (fraction containing the highest activity after chromatography on the Superdex 75 molecular-sieve column) ; lanes 2, active soluble DmpA
purified from E. coli ; lanes 3, active soluble DmpB purified from O. anthropi LMG7991. Identical RF values were obtained with the zymogram method using D-Ala-p-Na as a substrate.
Production of the wild-type and modified enzymes
The wild-type protein was purified as described above. For each
mutant, 10 ml of LB$ampicillin medium were inoculated with a
few colonies and the culture grown for 8 h at 28 !C. These
precultures were diluted in 250 ml of the same medium and
grown for 16 h at 28 !C. Cells were collected by centrifugation,
resuspended in 15 ml of buffer A and disrupted. The DNA was
digested with benzonase (16 h at 4 !C) in the presence of 2 mM
MgCl
!
. Cell extracts were then centrifuged, and the supernatants
analysed by dot-blot with rabbit anti-DmpA antibodies and by
SDS!PAGE (15% polyacrylamide) followed by electroblotting
and immunodetection as described above.
Chemical procedures
N-terminal sequences were determined as described previously
[5] on a 477A pulsed-liquid sequenator. Approximate M
r
values
were obtained by SDS!PAGE (15% polyacrylamide), and ac-
curate values by electrospray MS. Isoelectric points were meas-
ured by isoelectric focusing on Ampholine PAGplates, pH
3.5–9.5, detection of the active bands with the -Ala-p-Na
substrate [1] and measurement of the pH at the position of the
active protein. The activity could also be detected directly after
electrophoresis on non-denaturing 8% polyacrylamide gels by
the same zymogram technique. Protein concentrations were
estimated on the basis of the absorbance at 280 nm or with the
help of the BCA protein assay kit (Pierce, Rockford, IL, U.S.A.).
After SDS!PAGE, the intensities of Coomassie Brilliant Blue-
stained bands were compared with those of protein standards.
Gel scanning was done using the Cybertech CS-1 System.
Substrate acetylation was performed as described previously [1].
Kinetic measurements
The enzyme activity was measured in 50 mM potassium phos-
phate, pH 8.0, or 100 mM Tris, pH 8.0, at 30 !C. For substrates
containing a p-nitroaniline leaving group, variations of ab-
sorbance were monitored with the help of HP8452A or Uvikon
spectrophotometers, at 405 nm for #
"
measurements (∆ε%
11500 M−#"cm−#) and at 440 nm (∆ε% 2250 M−#"cm−#) for com-
plete time-course analysis. With substrates containing an N-
terminal -alanine, the released -alanine was quantified by the
-amino-acid oxidase method [6]. Liberation of -alanine from
the peptide N-terminus was measured by oxidation with -





parameters were obtained by non-linear
regressions of the #
"
values using the ENZFITTER software
package (Elsevier Biosoft, Cambridge, U.K.) or by analysis of
the complete time-courses with the help of the integrated
Henri–Michaelis equation [8]. Estimated errors on #
"
values were
! 10%. The degradation of non-chromogenic substrates was
monitored by withdrawing samples at various times, separating
the substrates and products by TLC at 20 !C and detecting their
amino groups using ninhydrin [9]. Degradation of unstable
substrates in the absence of enzyme was also monitored to
account for their spontaneous degradation. The TLC solvent
was n-butanol!acetic acid!5% NH
$
OH in water (5.5 :3 :1.5,
v!v!v). After ninhydrin revelation, the resulting picture was
digitalized and analysed by densitometry with the Cybertech CS-
1 system. Quantification was done by comparison with known
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quantities of standard peptides and amino acids corresponding
to the products expected in the reaction mixture. The estimated
errors on product quantification were &20%.
RESULTS
Production and purification of DmpA
E. coliDH5α cells harbouring the pDML1102 plasmid contained
inclusion bodies but also a high amount of soluble -Ala-p-Na-
hydrolysing activity. After purification to more than 95%
homogeneity, only one protein band was detected upon non-
denaturing PAGE (Figure 2, panel II) and electrofocusing (results
not shown, pI% 5.0), but gel electrophoresis in the presence of
SDS revealed two polypeptides with respective M
r
values of
about 30000 and 15000 (Figure 2, panel I). These were electro-
transferred on to a PVDF membrane and submitted to N-
terminal amino acid sequencing, which yielded the TSQTPTR-
KPR and SIIVVLATDL sequences for the large and small
peptides, respectively. These corresponded to residues 2–11 and
250–259 of the protein deduced from the sequence of the cloned
gene. Antibodies were raised against the purified protein.
Presence of a potential precursor in the inclusion bodies
Inclusion bodies were solubilized and submitted to SDS!PAGE.
The highest-M
r
protein revealed by Coomassie Brilliant Blue
Figure 3 Sequence of the DmpA amidohydrolase
Hydrolysis of the Gly-249–Ser-250 peptide bond (boxed) cleaves the polypeptide precursor into two subunits : an α N-terminal and a β C-terminal peptides (by analogy with penicillin acylase).
Note that the N-terminal M residue is also absent in the mature active protein (arrow). Mr values were determined by electrospray MS.
Figure 4 Electrophoretic analysis of DmpA mutants and correlation with activity using D-Ala-p-Na as a substrate
Coomassie Brilliant Blue-stained gel (left) and immunoblots revealed with anti-DmpA antibodies (right) after SDS/PAGE (15% polyacrylamide) of the following samples : MM, pre-stained molecular-
mass standards (Bio-Rad) ; WTpur, wild-type purified DmpA protein (1.5 µg) produced by E. coli DH5α ; GA, GD, SA, SC, ST and WT, 15 µl of 10-fold diluted cell supernatants (equivalent to 25 µl
of culture) containing the various mutants (G249A, G249D, S250A, S250C and S250T) and the non-mutated (WT) DmpA enzyme. $, activity found ; #, no activity found.
staining reacted with the antibodies raised against the soluble
and active DmpA (Figure 2, panel I). Its migration rate corres-
ponded to an M
r
value of about 45000, indicating that it might
represent a precursor of the active enzyme. This hypothesis was
corroborated by the identification of the first 10 N-terminal
residues of the solubilized protein. These corresponded exactly
with the N-terminal sequence of the large polypeptide, which was
preceded by the Met residue corresponding to the first ATG
codon of the gene. Attempts to obtain active enzyme by successive
denaturation of the inclusion bodies and renaturation remained
unsuccessful. The active protein was submitted to electrospray
MS and two peptides exhibiting M
r
values of 26564.3&2.6 and
13736.8&0.6 were found. These values corresponded well with
the M
r
values calculated on the basis of the sequences for
residues 2–249 (M
r
26565) and 250–375 (M
r
13737). These
results suggested that the active protein was derived from the
precursor by elimination of the N-terminal Met residue and
cleavage of the Gly-249–Ser-250 peptide bond without additional
loss of residues (Figure 3).
Absence of detectable precursor in O. anthropi
A sample of partially purified enzyme from an O. anthropi
culture [1] was submitted to non-denaturing PAGE and to
polyacrylamide-gel isoelectric focusing. In both cases, a zymo-
gram revealed the presence of -Ala-p-Na-hydrolysing activities
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Table 1 Activity of DmpA on Xaa-p-Na substrates
Values have S.D.s of&10%. The following substrates were also hydrolysed by DmpA : L-Leu-
p-Na (0.5% of Gly-p-Na), L-Met-p-Na (0.2%) and L-Val-p-Na (0.02%). Acetyl-D-Ala-p-Na,
D-Leu-p-Na and D-Phe-p-Na were not hydrolysed significantly (! 0.005%). ND, not determined.
DmpA
Substrate kcat (s−
1) Km (mM ) kcat/Km (M−
1"s−1)
Gly-p-Na* 70 3 23000
Gly-p-Na† 70 3 23000
L-Ala-p-Na* 0.5 0.6 800
L-Ala-p-Na† 0.56 0.36 1550
D-Ala-p-Na* 4.0 0.54 7500
D-Ala-p-Na† 3.3 0.52 6300
L-Lys-p-Na† 0.11 0.4 275
L-Arg-p-Na† 0.14 0.4 350
L-Phe-p-Na† ND ND 17
* In 100 mM Tris/HCl, pH 8.0, at 30 !C.
† In 50 mM potassium phosphate, pH 8.0, at 30 !C.
Table 2 Hydrolysis of dipeptides by DmpA
The substrate concentrations were 10 mM unless otherwise stated. The rate values have S.D.s
of &20%. The following compounds were not hydrolysed significantly (! 0.005 µmol/min
per mg of enzyme) : acetyl-Gly-Gly, D-Ala-Gly, L-His-Gly, L-Asp-Gly, benzoyl-Gly-L-Ala, phenyl-





















L-Phe-L-Phe (3 mM) 0.07
in positions identical to those observed with the fully purified
DmpA produced by E. coli. In the first case, a positive response
to the antibodies after electroblotting was also observed (Figure
2, panel IId). After SDS!PAGE, a similar analysis of the same
partially purified fractions highlighted two polypeptides in the
same positions as those observed with the purified E. coli protein
(Figure 2, panel Ib). The active enzymes produced by E. coli and
O. anthropi also behaved similarly uponmolecular-sieve filtration
on Superdex 75 and chromatography on QSFF. By contrast, the
45000-M
r
inactive precursor was never observed in O. anthropi
cell extracts.
Table 3 Hydrolysis of tripeptides by DmpA
The substrate concentrations were 10 mM unless otherwise stated. The rate values have S.D.s
of &20%. The following compounds were not hydrolysed significantly : acetyl-Gly-Gly-Gly,
acetyl-L-Ala-Gly-Gly and D-Leu-Gly-Gly.










L-Phe-L-Phe-L-Phe (1 mM) 0.18
Table 4 Influence of the length of the peptide chain on the activity of DmpA
The substrate concentration was 2 mM in all cases. Values have S.D.s of &20%.








At the stationary phase of growth, all E. coli cells producing the
wild-type enzyme and the five mutants contained inclusion
bodies, which were visualized by phase-contrast microscopy.
Moreover, SDS!PAGE analysis of cell supernatants followed by
Western-blot detection with anti-DmpA antibodies showed that
all the mutant-producing cells contained a soluble protein whose
electrophoretic mobility corresponded to that of the wild-type
DmpA precursor, a 45 kDa protein, and which was recognized
by the antibodies (Figure 4). By contrast, under the same
conditions, the supernatant from cells producing the wild-type
DmpA contained both uncleaved soluble precursor and cleaved
protein. Incubating all cell extracts for several hours at 30 !C
alone or in the presence of purified active wild-type DmpA failed
to further cleave the soluble precursors. Of all samples, only the
cell extract containing the wild-type enzyme was active on the -
Ala-p-Na substrate. This showed that cleavage and activity were
related phenomena and that the intact Gly-249–Ser-250 site was
essential for processing of the precursor into an active enzyme.
Note that host cells that did not contain the plasmid or which
harboured a plasmid devoid of the dmpA insert did not produce
inclusion bodies and that the corresponding supernatants were
devoid of proteins yielding positive Western-blot responses.
Kinetic characterization of DmpA
Activity was first measured towards Xaa-p-Na chromogenic
substrates (Table 1). For these artificial peptide analogues, the
highest activity was recorded with Gly and -Ala derivatives. An
activity profilewas also establishedwith a set of peptide substrates
(Tables 2–4). Hydrolysis of tripeptides exhibiting different resi-
dues at their N- and C-termini was monitored to determine the
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Figure 5 Hydrolysis of 10 mM tripeptides : Gly-Gly-L-Ala (a), L-Ala-Gly-Gly
(b) and D-Ala-Gly-Gly (c) by 9.2 µM DmpA at 30 !C in 50 mM potassium
phosphate, pH 8.0
Products were quantified after TLC and treatment of the plates with ninhydrin, as explained in
the text. Gly and Gly-L-Ala (a) could not be well separated, and were quantified by comparison
with the Gly standard. (a)!, Gly$Gly-L-Ala ;", Gly-Gly-L-Ala ;#, L-Ala. (b)!, Gly ;$,
Gly-Gly ; ", L-Ala-Gly-Gly ; #, L-Ala. (c) !, Gly ; ", D-Ala-Gly-Gly ; #, D-Ala.
preferential site of DmpA action. Figure 5 shows that the first
products of tripeptide hydrolysis were always the N-terminal
residues, and that the release of C-terminal residues was signifi-
cantly delayed when compared with the release of N-terminal
residues. These results suggest that C-terminal residues were only
liberated when the dipeptide formed during the first reaction step
was hydrolysed by DmpA. Note that tripeptides were better
substrates than dipeptides (Tables 2 and 3), with the exception of
-Ala-Gly-Gly, which was a very poor substrate : in this case, the
Gly-Gly dipeptide was not an observable product and was thus
Figure 6 Hydrolysis of 2 mM Gly5 by 2.1 µM DmpA in 50 mM potassium
phosphate, pH 8.0, at 30 !C
The accumulation of the various intermediates is also shown :!, Gly ;%, Gly2 ;$, Gly3 ;&,
Gly4 ; ", Gly5.
Table 5 Activity of DmpA on simple ester and amide substrates
The substrate concentration was 10 mM in all cases. The values have S.D.s of &20%.









hydrolysed as soon as it was formed. Peptide degradation studies
in the Gly
n
series showed that the products appeared as the result
of the release of one Gly from one extremity (exoprotease) and
that the better substrates were tetra-, penta- and tripeptides (in
that order, see Table 4 and Figure 6), whereas the dipeptide
accumulated. An activity profile was also determined for residues
in the N1 (the first N-terminal residue) and N2 (the following
residue) positions, their configuration and their number (Tables
2–4). Acetylation of the substrate N-terminus suppresses the
activity, a result showing that DmpA only recognizes substrates
with a free N-terminal amino group. DmpA thus belongs to the
aminopeptidase group of enzymes (EC 3.4.11). However, DmpA





-Ala-p-Na (Table 1). Hence, DmpA is also a -Ala-amidase-
esterase. Note that the specific activity of DmpA towards -Ala-
p-Na was much weaker than that of the Dap enzyme, a strict -
aminopeptidase [2].
DmpA inhibition
The following protease inhibitors were tested unsuccessfully
(30 min pre-incubation at 30 !C, at the concentration advised by
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the supplier but also with 10-fold higher concentrations) : anti-
pain, aprotinin, bestatin, chymostatin, trans-epoxysuccinyl--
leucylamido-(4-guanidino)butane (E-64), EDTA, leupeptin,
pefabloc SC and 1,10-phenanthroline.
DISCUSSION
DmpA as a new N-tn amidohydrolase
The sequence of the purified DmpA protein confirmed that its
structural gene was the ORF identified downstream of the lacZ
promoter on the pDML1102 plasmid that encoded a 375-residue
polypeptide. However, the soluble active protein produced in E.
coli consisted of two distinct polypeptides corresponding to
residues 2–249 (α-subunit) and 250–375 (β-subunit), as shown by
N-terminal sequencing and electrospray MS (Figure 3). The
absence of signal peptide was in agreement with the intracellular
location of the protein. The enzyme was not purified from the
original O. anthropi strain, where the quantities produced were
too small, but the analysis of a crude preparation by immuno-
logical methods indicated the presence of two polypeptides of
sizes similar to those of the α- and β-subunits. Upon over-
production in E. coli, large quantities of inclusion bodies that
contained the complete and uncleaved polypeptide accumulated,
but failed to yield active enzyme after solubilization. In some
cases, small quantities of the large polypeptide were obtained in
a soluble form (Figure 4), but it was not further processed upon
incubation of the crude extract. In the mature protein, the two
subunits remain associated by non-covalent bonds, since the
sequence highlights only one Cys residue at position 180 of the
precursor.
The cleavage of the 249–250 peptide bond could result from
either the action of a cytoplasmic protease or self-processing.
The facts that this cleavage, although very specific (see below),
occurred in bothE. coli andO. anthropi, and that the unprocessed
protein was not observed in the latter strain, argued in favour of
the second hypothesis. The cleaved Gly–Ser peptide bond is
identical to the autocatalytic processing sites of the AcyII
cephalosporin acylases produced by various Pseudomonas strains
[10,11], and is generally similar to that found in N-tn amido-
hydrolases (Table 6).
Numerous site-directedmutagenesis results have been obtained
with various N-tn hydrolases : 20S proteasomes [12,13], penicillin
acylases [14,15], Bacillus subtilis PRPP amidotransferase [16,17],
Fla#obacterium meningosepticum aspartyl glucosaminidase [18]
and the MIP (intein-extein) in #itro splicing system [19,20]. By
analogy, five mutants were produced at the DmpA cleavage site.
All the modified proteins were produced with similar good yields
but remained both uncleaved and inactive, even when Ser-250
(position n) was replaced by other potential nucleophilic residues
such as Thr or Cys. With the other N-tn hydrolases, mutations
performed either at the n#1 or n positions, and which prevent
cleavage, always result in a loss of activity [12,14,15,17,18,30].
Conversely, in position n, substitution by a residue with a
nucleophilic side-chain sometimes allows processing but only
yields an active enzyme in the case of the 20 S proteasome Thr#
Ser mutant [12]. This suggests that the geometries necessary for
cleavage and activity are different, and this is not surprising,
since the free α-amino group of residue n that acts as a general
base in the enzymic activity cannot play the same role in the
cleavage reaction.
An analysis of the DmpA sequence with the help of the Chou
and Fasman algorithm [31] shows that the N-terminal Ser of the
β-subunit is located at the N-terminus of a β-sheet structure, in
exactly the same way as the active nucleophile residue in N-tn
hydrolases. The N-terminal Ser-1–Lys-18 peptide of the small β-
subunit is highly hydrophobic (results not shown) and the fact
that this subunit is not well recognized by antibodies raised
against the native protein (Figure 2) suggests that most of it is
buried inside the protein core. All these results indicate that
DmpA might be the first representative of a new subfamily of N-
tn hydrolases. The crystal structure of DmpA, which has now
been solved at a resolution of 1.82 A" [C. Bompard-Gilles, V.
Villeret, L. Fanuel, J.-M. Fre# re and J. Van Beeumen, unpub-
lished work], confirms this assumption and shows a clear
similarity between the fold of DmpA and that of the N-tn
amidohydrolases of known structure [32].
A search of the databases (see the Introduction) revealed that
the genomes of Pyrococcus horikoshii, Pseudomonas aeruginosa,
Ps. fluorescens, Bordetella pertussis and Neisseria meningitidis
contained ORFs encoding putative proteins very similar to
DmpA (Table 6). When these sequences are compared with that
of DmpA, Gly and Ser residues align with the position-249–250
Gly!Ser dyad of DmpA. Moreover, the sequences downstream
of this dyad are nearly identical (Table 6) but, as in other N-tn
hydrolases, the sequences upstream of the cleavage site are much
less conserved. Lower degrees of similarity were found with
putative proteins encoded by ORFs in the genomes of Myco-
bacterium leprae and M. tuberculosis. In these cases, alignments
highlight striking similarities downstream of a potential cleavage
site formed by an Asn!Thr dyad, which is reminiscent of the
Gln!Thr or Asp!Thr cleavage sites in other N-tn hydrolases
(Table 6). Surprisingly, these two putative mycobacterial proteins
exhibit a significant similaritywith thewell-characterized amidase
NylC, a nylon hydrolase produced by Fla#obacterium sp. K172
[29]. It is thus very tempting to assume that all these proteins are
cleavage-activated N-tn hydrolases and that the DmpA family
can be divided into two subfamilies, containing either Gly!Ser-
or Asn!Thr-cleavage sites. It can also be expected that all these
proteins, when isolated, will exhibit amidohydrolase activities, as
already demonstrated for theNylC enzyme, and that themembers
of the ‘Gly!Ser’ subfamily will behave as aminopeptidases.
It should be noted finally that the consequences of the
elimination of the N-terminal Met of DmpA on the enzyme’s
activity remain undetermined.
Enzymic characterization of DmpA
DmpA liberates the N-terminal residues from peptide substrates







. Tripeptides of the formXaa-Gly-Gly are hydro-
lysed with a consistently higher efficiency than the corresponding
Xaa-Gly dipeptides ; in the Gly
n
series, the tetrapeptide is the
best substrate. To allow recognition, the substrate α-amino
groupmust be free (peptides whoseN-terminus has beenmodified
are not degraded) and optimal activity requires an N-terminal
residue in an -configuration. ThusDmpAmaypossess a negative
charge in the substrate-binding pocket that could stabilize the N-
terminal positive charge of the peptide substrate and position it
in a catalytically productive geometry, as observed in the PepC
aminopeptidase [33]. Its catalytic profile for residues at the first
N-terminal position in dipeptides is : basic amino acid (Arg, Lys)
$Phe$ aliphatic amino acid (Leu, Gly, Ala)$hydroxylated
amino acid (Ser). An acidic residue in the first or second N-
terminal position precludes hydrolysis. This underlines the impor-
tance of the N-terminal charge of the substrate on its hydrolysis :
a double positive charge (basic amino acid) favours substrate
binding and hydrolysis, whereas an ionized acidic group is
detrimental to the activity. Dipeptides exhibiting a His or a Trp
residue at the N-terminus are not hydrolysed. A Phe at the
second position from theN-terminus increases theDmpAactivity
" 1999 Biochemical Society
154 L. Fanuel and others
Table 6 Alignment of the cleavage sites of N-tn and potential N-tn amidohydrolases
The N- and C-terminal residues of the cleaved peptide bond are shown in bold. The cleavage either eliminates an N-terminal propeptide of variable length or yields two subunits with or without
the concomitant elimination of a propeptide or an internal peptide (both processes occur in penicillin acylase [25]). Some other enzymes might also be related to N-tn hydrolases [26] : Pseudomonas
7A glutaminase-asparaginase [27] and Lactobacillus 30a histidine decarboxylase [28]. aa, amino acids. Addresses in data banks : a, DDBJ$AB009466 ; b, gnl$PAGP$P. aeruginosa%contig 163 ; c,
gb $AF004848 ; d, gnl $Sanger $B. pertussis%contig 578 ; e, gnl $TIGR $GNMCQ43R ; f , gb $U00014 $M. leprae cosmid B1549%C2%208 ; g, EMBL$Z73902$M. tuberculosis H37Rv.
Enzyme






Proteasome 20 S (β-subunit)
Thermoplasma acidophilum * 1 MNQTLETGTTTVGITLKDAV 20 211 aa Propeptide [12]
Human (Z)† 36 LPKVRKTGTTIAG 48 Propeptide [12,13]
Glutamine PRPP amidotransferase
Bacillus subtilis* 4 EIKGLNEECGVFG 16 465 aa Propeptide [16]
Saccharomyces cerevisiae† 1 MCGILG 6 Propeptide [16]
Chicken† 4 EELGIREECGVFG 16 Propeptide [16]
Aspartylglucosaminidase or
glycosylasparaginase
Human* 198 TEDDRGHDTIGMVVIHKTGH 217 346 aa 2 Subunits [21]
Flavobacterium meningosepticum† 189 IVNIENHDTIGMIALDAQGN 208 340 aa 2 Subunits [18]
γ-Glutamyltranspeptidase‡
E. coli 383 LAPYESNQTTHYSVVDKDGN 402 580 aa 2 Subunits [22]
Human 374 YTP-DDGGTAHLSVVAEDGS 392 580 aa 2 Subunits [22]
Penicillin acylase
E. coli * 282 GLAGYPTTSNMWVIGKSKAQ 301 846 aa 2 Subunits [14,15,23]
Kluyvera citrophila† 282 GLAGYPTTSNMWVIGKNKAQ 301 844 aa 2 Subunits [24]
Cephalosporine acylase‡
AcyI Pseudomonas sp. SE83 360 LSGGESADTTHVTVADAMGN 379 558 aa 2 Subunits [10]
AcyII Pseudomonas sp. SE83 232 ASDAAGGGSNNWAVAPGRTA 251 774 aa 2 Subunits [10]
Pseudomonas sp. SY-77-1 191 PPDLADQGSNSWAVAPGKTA 210 311 aa 2 Subunits [11]
DmpA or putative proteins
potentially related to DmpA
O. anthropi 242 QSQLQERGSIIVVLATDLPL 261 375 aa 2 Subunits This study
Pyococcus horikoshii 231 GRGGEGKGSIIMIIATDAPL 250 361 aa ? (a)
Ps. aeruginosa 233 EEGTPGMGSIVVILATDAPL 252 370 aa ? (b)
Ps. fluorescens§ ERGTPGMGSIVVIIATDAPL ? (c)
Bordetella pertussis¶ PAGQPEKGSIILLLATDAPL ? (d)
Neisseria meningitidis¶ TMMQENGSLIVWHGQDKPL ? (e)
Mycobacterium leprae 236 KSPLSALNTTIGVVATDATL 255 362 aa ? (f)
Mycobact. tuberculosis H37rv 225 GAFNTPFNTTIGVIACDAAL 244 344 aa ? (g)
6-Aminohexanoate oligomer
hydrolase (nylon hydrolase)
Flavobacterium 259 PPVTEAGNTTISAIVTNVRM 278 355 aa ? [29]
* Enzymes whose three-dimensional structure have been determined and for which the involvement of the β-subunit N-terminal residue in the catalytic process has been demonstrated.
† Enzymes exhibiting catalytic properties and sequence analogies with the first group.
‡ Potential N-tn hydrolases [32].
§ Incomplete ORF.
¶ Complete ORF not available.
towards dipeptide substrates and the best-hydrolysed dipeptide
substrate was -Arg--Phe. It is also interesting to note that the
stereospecificity requirements do not appear to be absolute, since
the Gly--Ala dipeptide and the -Ala-Gly-Gly tripeptide were
hydrolysed significantly, although 4- and 30-fold less efficiently
than the -isomers, respectively. Among all the peptides tested,
-Ala-Gly-Gly was the best substrate.
Simple amino acid amides and ester derivatives were also
hydrolysed by DmpA, with Gly derivatives as the best substrates.
However, in this case, marked differences were observed when
compared with the ‘normal ’ peptides. First, the p-nitroanilide
derivatives of -Arg, -Lys, -Leu and -Phe were much poorer
substrates than Gly-p-Na, in sharp contrast to the results
obtained with the dipeptides. Secondly, and more strikingly, the
-Ala derivatives were hydrolysed 3–10-fold faster than their -
Ala counterparts. However, this does not hold for larger amino
acids, since -Leu-p-Na and -Phe-p-Na were not hydrolysed at
all. The recognition of -Xaa derivatives thus seems to be limited
to -Ala: DmpA is thus also a -Ala-amidase-esterase. We
verified that two well-characterized -aminopeptidases, micro-
somal leucine aminopeptidase from pig kidney and amino-
peptidase I from Streptomyces griseus, were nearly inactive on
the -Ala-p-Na stereoisomer (-Ala-p-Na!-Ala-p-Na% 0.005
and 0.01, respectively). Moreover, no mention of this type of -
stereospecific activity for -aminopeptidases is found in the
literature [33]. This double -aminopeptidase!-amidase-esterase
activity seems to be an original property of the DmpA enzyme,
although it has been shown that the exact structure of the
substrate might influence the stereospecificity of lipases [34,35]
and-peptidases [36], a phenomenon that is generally attributed
to steric hindrance or to the quality of the leaving group.
We demonstrate here that the specificity profile for chromo-
genic p-nitroanilide substrates reflects the activity of the enzyme
on simple amide and ester derivatives rather than on ‘normal ’
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peptides. The former compounds probably bind into the enzyme
active site in a somewhat different way, resulting in a modified
position of their scissile bonds relative to the enzyme catalytic
groups. More detailed hypotheses attempting to explain such a
‘changing’ stereospecificity will have to rely on the detailed
analysis of the DmpA protein’s three-dimensional structure.
Nevertheless, the kinetic results show that attempts to charac-
terize a new peptidase with chromogenic substrates can only be
hazardous, as also noted by Niven [37,38].
Possible physiological roles of DmpA and DmpB
Thus O. anthropi produces both DmpA, an -aminopeptidase,
and DmpB [1] or Dap [2], two very similar -aminopeptidases.
To date, this latter activity has only been found in this species,
which has been recently separated from theAchromobacter genus
[39] and is still poorly characterized. These - and -amino-
peptidases are probably parts of the general peptidase pool of O.
anthropi, enzymes used by these highly proteolytic bacteria to
extract amino acids from peptides present in the medium. In this
respect, it is interesting to note that DmpA appears to exhibit a
rather wide specificity profile and might thus contribute to the
hydrolysis of a vast number of small peptides transported into
the cell. Similarly, Lactococcus lactis possesses a set of proteases,
among which are 8–10 intracellular or membrane-bound amino-
peptidases, that produce the essential amino acids from milk
proteins (for instance, see [40]). The physiological role of the
DmpA-like proteins whose encoding gene was found in other
species remains mysterious.
Conversely, bacteria producing enzymes that act on molecules
containing amino acids in the -configuration, such as DmpB,
could hydrolyse bacterial cell-wall-degradation products present
in the medium. Some strains of Bacillus, a highly proteolytic
bacterial genus, also produce enzymes acting on -amino acid-
containing peptides [41,42]. However, it seems that these enzymes
do not take part in intracellular peptidoglycan recycling. So far,
no enzymic activity has been discovered that liberates a peptido-
glycan-degradation product exhibiting an N-terminal -amino
acid residue in the cell cytoplasm. A -Ala--Ala dipeptidase
(VanX) involved in vancomycin resistance has been described
and well studied [43], but its sequence does not exhibit any
similarity with those of Dap and DmpB.
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